EANM/SNMMI/IHPBA联合操作指南:[(99m)Tc]Tc-美溴西宁肝胆闪烁显像SPECT/CT定量评估未来肝残余功能
该联合指南由EANM、SNMMI和IHPBA制定,针对[(99m)Tc]Tc-美溴西宁肝胆闪烁显像(HBS)在肝切除、选择性内放射治疗(SIRT)或肝脏再生程序前后定量评估未来肝残余(FLR)功能提供标准化方案与推荐。指南强调HBS应作为容积测量的补充而非替代,用于识别易发生肝切除后肝衰竭(PHLF)和SIRT后肝衰竭的高危患者,并促进全球实施。
要点
- HBS用于未来肝残余功能定量评估和风险分析,纳入标准诊疗是容积测量的补充而非替代。
- 指南标准化HBS方案,涵盖临床指征、采集、后处理分析、解读及截断值。
- HBS有助于识别疑似和未疑似的高危患者,这些患者易发生PHLF和SIRT后肝衰竭。
核心结论
- HBS全球兴趣增加需要实施指导,标准化促进其适用性和全球推广;HBS纳入标准诊疗旨在补充风险评价,识别易发生PHLF和SIRT后肝衰竭的高危患者,而非替代容积测量。
研究设计与样本
- EANM/SNMMI/IHPBA联合制定的操作指南,提供HBS标准化方案及临床指征、考虑因素、临床应用、截断值、相互作用、采集、后处理分析和解读的推荐。
诊断标准与关键数值
- 指南提供HBS的截断值用于未来肝残余功能定量评估和风险分析,具体数值见原文。
临床应用与阅片要点
- 指南推荐标准化HBS方案以促进全球实施,HBS用于肝切除、SIRT或肝脏再生程序前后的定量功能评估。
- HBS纳入标准诊疗是补充容积测量进行风险评价,识别易发生PHLF和SIRT后肝衰竭的高危患者。
局限性
- 原文未报告局限性。
英文原文(摘要)· 点击展开
HPB (Oxford). 2023 Oct;25(10):1131-1144. doi: 10.1016/j.hpb.2023.06.001. Epub 2023 Jun 2. ABSTRACT PURPOSE: The aim of this joint EANM/SNMMI/IHPBA procedure guideline is to provide general information and specific recommendations and considerations on the use of [ 99m Tc]Tc-mebrofenin hepatobiliary scintigraphy (HBS) in the quantitative assessment and risk analysis before surgical intervention, selective internal radiation therapy (SIRT) or before and after liver regenerative procedures. Although the gold standard to estimate future liver remnant (FLR) function remains volumetry, the increasing interest in HBS and the continuous request for implementation in major liver centers worldwide, demands standardization. METHODS: This guideline concentrates on the endorsement of a standardized protocol for HBS elaborates on the clinical indications and implications, considerations, clinical appliance, cut-off values, interactions, acquisition, post-processing analysis and interpretation. Referral to the practical guidelines for additional post-processing manual instructions is provided. CONCLUSION: The increasing interest of major liver centers worldwide in HBS requires guidance for implementation. Standardization facilitates applicability of HBS and promotes global implementation. Inclusion of HBS in standard care is not meant as substitute for volumetry, but rather to complement risk evaluation by identifying suspected and unsuspected high-risk patients prone to develop post-hepatectomy liver failure (PHLF) and post-SIRT liver failure. PMID: 37394397 | DOI: 10.1016/j.hpb.2023.06.001
引用
- 指南共识 · 腹部影像:Joint EANM/SNMMI/IHPBA procedure guideline for [(99m)Tc]Tc-mebrofenin hepatobiliary scintigraphy SPECT/CT in the quantitative assessment of the future liver remnant function
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。